Thrombotech Ltd.: Clinical Trials

1 trial sponsored by Thrombotech Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Thrombotech Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)
THR-18, Placebo - Acute Ischemic Stroke
Phase 1 / Phase 2UnknownThrombotech Ltd.222011-03-012010-12-03

Conditions studied

Ischemic Stroke (1)

Countries

Israel (1)

Top investigators

Ronen R. Leker, MD, FAHA (1)